QCM Cayman’s Vaxart VXRT Stock Holding History

QCM Cayman’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-13,654	Closed	-$102K	–	182
2021 Q2	$102K	Sell	13,654 -470	-3%	-$3.28K	0.26%	110
2021 Q1	$85K	Buy	+14,124	New	+$109K	0.26%	88

Other funds holding VXRT

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

QCM Cayman's VXRT Position: Q3 2021 in Review

QCM Cayman sold out of Vaxart (VXRT) in Q3 2021, closing a stake of 13,654 shares — an estimated $102K sold.

QCM Cayman first reported a position in VXRT in Q1 2021 and held it in 2 quarters. The position peaked at $102K in Q2 2021. 141 funds tracked by Wall St. Rank hold VXRT as of Q3 2021.

QCM Cayman reported no remaining Vaxart position as of Q3 2021 after selling out during the quarter.
QCM Cayman sold 13,654 Vaxart shares in Q3 2021, an estimated $102K.
QCM Cayman first reported a position in Vaxart in Q1 2021 and held it in 2 quarters.
QCM Cayman's Vaxart position peaked at $102K in Q2 2021.
141 funds tracked by Wall St. Rank held Vaxart as of Q3 2021.

Based on QCM Cayman's 13F filing for Q3 2021, filed 1 Nov 2021.